According to the Zhitong Finance App, Sinopharm Holdings (01099) announced Sinopharm's consistent results for the six months ended June 30, 2026, with total operating income of 36.266 billion yuan, a decrease of 1.44% year on year; net profit attributable to shareholders of listed companies was 606 million yuan, a decrease of 8.97% year on year; basic earnings per share were 0.99 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.